Cristian Massacesi: I never fail to be impressed by my teams’ commitment in delivering science
Cristian Massacesi, Chief Medical Officer & Oncology Chief Development Officer at AstraZeneca, made the following post on LinkedIn:
“ESMO23 was another resounding success! Wonderful, as always, to be among those who traveled from around the world to be here – to witness the scientific advancements and soak up the weekend’s events. I was impressed by the breadth of oncology data shared by our industry, and the depth of collaboration that makes such progress possible.
I never fail to be impressed by my teams’ commitment in delivering science and by the presentations which this time illustrate how we are aiming to improve outcomes for patients across lung, breast, gynecological and GU/GI tumors. With every congress, we’re showing more progress and more breakthroughs, and I couldn’t be prouder of what we’re building here at AstraZeneca.
Congratulations on a successful ESMO!”
Source: Cristian Massacesi/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023